Interview Versus Performance Assessment of Cognition as Predictors of Real-World Outcomes in a Large-Scale Cross-Sectional Study in Schizophrenia.
cognitive assessment interview
cognitive impairment
coprimary measure
functional capacity
negative symptoms
real-life functioning
schizophrenia
social cognition
Journal
Schizophrenia bulletin open
ISSN: 2632-7899
Titre abrégé: Schizophr Bull Open
Pays: United States
ID NLM: 101770329
Informations de publication
Date de publication:
Jan 2024
Jan 2024
Historique:
medline:
2
9
2024
pubmed:
2
9
2024
entrez:
2
9
2024
Statut:
epublish
Résumé
The Cognitive Assessment Interview (CAI) is an interview-based scale measuring cognitive impairment and its impact on functioning in subjects with schizophrenia (SCZ). It is approved as a coprimary measure of performance-based instruments, such as the Measurement and Treatment Research to Improve Cognition in Schizophrenia Consensus Cognitive Battery (MCCB). Recent research highlights negative symptoms, social cognition, and functional capacity as mediators of cognitive impairment's impact on functioning. This study compared mediation analysis outcomes using CAI or MCCB scores, providing insights into the utility of interview-based tools in research and clinical practice. The study included 618 individuals diagnosed with schizophrenia, recruited from 24 Italian psychiatric clinics. Neurocognitive assessments utilized both CAI and MCCB. Mediation analyses explored negative symptoms, social cognition, and functional capacity as mediators of the impact of neurocognition on real-life functioning domains. The study's results extend the validation of the CAI as a coprimary measure that provides valid information on the impact of cognitive impairment on real-life functioning and its possible mediators, complementing the information obtained using the MCCB. Interview-based cognitive assessment might be essential for understanding schizophrenia complexity and its impact on various cognitive and functional domains for clinicians, patients, and caregivers.
Identifiants
pubmed: 39221412
doi: 10.1093/schizbullopen/sgae020
pii: sgae020
pmc: PMC11362673
doi:
Types de publication
Journal Article
Langues
eng
Pagination
sgae020Investigateurs
Luigi Giuliani
(L)
Andrea Perrottelli
(A)
Giuseppe Piegari
(G)
Eleonora Merlotti
(E)
Daria Pietrafesa
(D)
Francesco Brando
(F)
Noemi Sansone
(N)
Antonio Melillo
(A)
Marco Papalino
(M)
Vitalba Calia
(V)
Raffaella Romano
(R)
Pietro Calcagno
(P)
Martino Belvedere Murri
(M)
Simone Cattedra
(S)
Cristiana Montemagni
(C)
Cecilia Riccardi
(C)
Elisa Del Favero
(E)
Francesca Pacitti
(F)
Rodolfo Rossi
(R)
Valentina Socci
(V)
Informations de copyright
© The Author(s) 2024. Published by Oxford University Press on behalf of the University of Maryland's school of medicine, Maryland Psychiatric Research Center.